SCHEMBL578048

SCHEMBL578048

Cc1cc[nH]c1-c1[c]nc2ccccc2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 3/20 0.37
▸ CYP1A2 P05177 3/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ RAD52 P43351 1/20 0.33
▸ SMARCA2 P51531 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPT P10636 4/20 0.32
▸ CFB P00751 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.31
▸ PKM P14618 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31
▸ PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1379790 0.69 NPC1 (0.53) NPC1MAPT
SCHEMBL578186 0.69 MAPT (0.42) NQO2NPC1ALDH1A1HPGDRAB9A
SCHEMBL585626 0.68 NPC1 (0.60) NPC1ALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL410281 0.68 MAPT (0.46) NQO2CYP1A2NPC1ALDH1A1HPGD
SCHEMBL15577812 0.67 ATM (0.42) NQO2NPC1ALDH1A1HPGDRAB9A
SCHEMBL6643019 0.67 ALDH1A1 (0.43) NQO2NPC1ALDH1A1HPGDRAB9A
SCHEMBL9843907 0.66 ALDH1A1 (0.40) NQO2ALDH1A1HPGDRAB9AMAPT
SCHEMBL577716 0.65 MAPK10 (0.44) CYP1A2NPC1ALDH1A1HPGDRAB9A
SCHEMBL577395 0.63 MAPT (0.32) MAPT
SCHEMBL578047 0.63 KDM4E (0.47) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 — — EP disclosed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 — — EP disclosed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 — — WO disclosed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 — — WO disclosed
Send feedback